Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Viatris
VTRS
|
+$53.9M |
| 2 |
Pinduoduo
PDD
|
+$46.6M |
| 3 |
Cloudflare
NET
|
+$44.2M |
| 4 |
Enphase Energy
ENPH
|
+$42M |
| 5 |
NIO
NIO
|
+$39M |
Top Sells
| 1 |
Apple
AAPL
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$198M |
| 3 |
Amazon
AMZN
|
+$138M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$76.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$76.7M |
Sector Composition
| 1 | Technology | 26.42% |
| 2 | Healthcare | 14.37% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Communication Services | 10.63% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Evercore
EVR
$13.2B
| $10.1M | 0.01% |
91,900
| – | – |
|
|
ARNA
927
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $10M | 0.01% |
130,305
+4,300
| +3% | +$330K |
|
|
ENV
928
DELISTED
ENVESTNET, INC.
ENV
| $10M | 0.01% |
121,600
+300
| +0.2% | +$24.7K |
|
929
Twist Bioscience
TWST
$1.52B
| $9.99M | 0.01% |
70,700
+5,700
| +9% | +$805K |
|
930
Ziff Davis
ZD
$1.52B
| $9.99M | 0.01% |
117,566
-575
| -0.5% | -$48.8K |
|
931
Hanover Insurance
THG
$6.48B
| $9.97M | 0.01% |
85,300
-800
| -0.9% | -$93.5K |
|
932
KBR
KBR
$6.38B
| $9.96M | 0.01% |
321,841
-700
| -0.2% | -$21.7K |
|
933
Grand Canyon Education
LOPE
$5.88B
| $9.95M | 0.01% |
106,900
-600
| -0.6% | -$55.9K |
|
934
iQIYI
IQ
$2.5B
| $9.95M | 0.01% |
569,161
+150,576
| +36% | +$2.63M |
|
|
CCMP
935
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $9.93M | 0.01% |
65,660
-200
| -0.3% | -$30.3K |
|
936
Glacier Bancorp
GBCI
$5.77B
| $9.92M | 0.01% |
215,700
-500
| -0.2% | -$23K |
|
937
ASGN Inc
ASGN
$2.31B
| $9.92M | 0.01% |
118,700
-300
| -0.3% | -$25.1K |
|
938
Fox Factory Holding Corp
FOXF
$1.19B
| $9.91M | 0.01% |
93,700
+6,200
| +7% | +$655K |
|
939
Advanced Drainage Systems
WMS
$11.3B
| $9.89M | 0.01% |
118,300
+1,400
| +1% | +$117K |
|
940
Rapid7
RPD
$1.29B
| $9.88M | 0.01% |
109,600
+900
| +0.8% | +$81.1K |
|
941
Editas Medicine
EDIT
$241M
| $9.87M | 0.01% |
140,800
+2,600
| +2% | +$182K |
|
|
BHVN
942
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $9.83M | 0.01% |
114,700
+1,900
| +2% | +$163K |
|
943
Verint Systems
VRNT
$1.23B
| $9.8M | 0.01% |
286,402
-589
| -0.2% | -$20.2K |
|
944
Concentrix
CNXC
$3.38B
| $9.77M | 0.01% |
+98,985
| New | +$9.77M |
|
945
Ashland
ASH
$2.47B
| $9.74M | 0.01% |
123,000
-300
| -0.2% | -$23.8K |
|
946
Vertiv
VRT
$52.3B
| $9.71M | 0.01% |
519,800
+36,000
| +7% | +$672K |
|
|
PE
947
DELISTED
PARSLEY ENERGY INC
PE
| $9.7M | 0.01% |
683,102
-1,500
| -0.2% | -$21.3K |
|
948
Kinsale Capital Group
KNSL
$10.2B
| $9.7M | 0.01% |
48,462
+500
| +1% | +$100K |
|
949
Frontdoor
FTDR
$4.88B
| $9.7M | 0.01% |
193,103
-400
| -0.2% | -$20.1K |
|
950
Alcoa
AA
$8.6B
| $9.69M | 0.01% |
420,394
-1,000
| -0.2% | -$23.1K |
|